Sanofi-Aventis Increases Bid For Zentiva To Reach Central, Eastern Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi-Aventis continues pushing to expand with an increased offer for Zentiva, which markets OTC drugs and dietary supplements as well as Rx products in Central and Eastern Europe.
You may also be interested in...
Graham Almond On Sanofi’s Plans to Build Zentiva Generics Brand In Southeast Asia: An Interview With PharmAsia News (Part 1 of 2)
PharmAsia News talks with Sanofi Vice President Southeast Asia, Global Operations Graham Almond to see how the company, with a long-standing presence in the region, is dealing with expansions in public health care coverage to grow its generics business.
South of the Border: Sanofi’s Tailored Approach To Emerging Markets
Sanofi’s recent acquisition of Medley, Brazil’s leading generics manufacturer, reflects its strategy of going local — and generic — in emerging markets.
South of the Border: Sanofi’s Tailored Approach To Emerging Markets
Sanofi’s recent acquisition of Medley, Brazil’s leading generics manufacturer, reflects its strategy of going local — and generic — in emerging markets.